• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:NYMXF)

0.0900 +0.0254 (+39.32%)
Streaming Delayed Price Updated: 3:10 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,601
Open 0.0900
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0646
Today's Range 0.0601 - 0.0900
52wk Range 0.0300 - 0.1999
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NYMOX Provides Current Update
June 02, 2026
Via ACCESS Newswire
News headline image
NYMOX Provides Recent Updates
March 27, 2026
Via ACCESS Newswire

Performance

YTD
+93.1%
+93.1%
1 Month
+63.6%
+63.6%
3 Month
+43.1%
+43.1%
6 Month
+72.4%
+72.4%
1 Year
-10.0%
-10.0%

More News

Read More
News headline image
Nymox Announces Dismissal of Delaware Action Against Ascella
March 11, 2025
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
NYMOX Announces Trading Resumed and New Listing on OTCQB Market
December 17, 2024
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Announces Filing of Annual Report
August 30, 2024
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Annual Report
July 18, 2024
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Required to Resubmit Application to DKMA
July 16, 2024
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
March 27, 2024
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox December 27 Message to Shareholders
December 27, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
November 30, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
November 21, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
November 09, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
November 03, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
November 03, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
November 02, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
October 31, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
October 27, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review
October 26, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH
September 25, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Reports Completion of $2 Million Private Placement
August 29, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Announces $2 Million Private Placement
August 02, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO
July 31, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire

Frequently Asked Questions

Is NYMXF publicly traded?
Yes, NYMXF is publicly traded.
What exchange does NYMXF trade on?
NYMXF trades on the OTC Traded
What is the ticker symbol for NYMXF?
The ticker symbol for NYMXF is NYMXF on the OTC Traded
What is the current price of NYMXF?
The current price of NYMXF is 0.0900
When was NYMXF last traded?
The last trade of NYMXF was at 06/05/26 03:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap